Peficitinib
CAS: 944118-01-8
Ref. 3D-UMB11801
| 1mg | Descatalogado | ||
| 2mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Peficitinib
Sinónimos:
- 4-[(anti-5-Hydroxyadamantan-2-yl)amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
- stereoisomer of 4-[(5-Hydroxytricyclo[3.3.1.13,7]dec-2-yl)amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
- 4-[(trans-5-Hydroxyadamantan-2-yl)amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
- 1H-Pyrrolo[2,3-b]pyridine-5-carboxamide, 4-[(5-hydroxytricyclo[3.3.1.13,7]dec-2-yl)amino]-, stereoisomer
Descripción:
Peficitinib is a selective inhibitor of the Janus kinase (JAK) family. It has been shown to inhibit the angiogenic process in vitro and in animal models, suggesting that peficitinib may be useful for the treatment of diseases with an underlying inflammatory component, such as rheumatoid arthritis and bowel disease. Peficitinib has also been shown to effectively reduce disease activity in patients with active rheumatoid arthritis. Peficitinib binds to and inhibits JAKs 1-3, which are involved in the inflammatory response.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
326.39 g/mol
Fórmula:
C18H22N4O2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
